Rugonersen for angelman syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 May 2026: Trial registered, NCT07605429
  2. 23 Jun 2026: Trial started, NCT07605429

The trials

NCT07605429: BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.

State
Under way
Phase
Phase 3
People
165 planned
Started
23 Jun 2026
Primary completion
Mar 2029
Arms
rugonersen
Results
None posted
  1. 26 May 2026: Trial registered
  2. 23 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.